Company intelligence / Profile preview

Bruker Spatial Biology

Seattle, WA, USAbrukerspatialbiology.com ↗

Ownership: Private
Development stage: Other

Overview

Bruker Spatial Biology is a leading provider of spatial molecular biology solutions. Its portfolio includes high-throughput instruments and software enabling single-cell resolution analysis of RNA/protein expression and genome architecture within tissues. The technologies are widely adopted in academic and biopharma R&D globally. No clinical trial results apply as it is a tools/platform company.

Modalities: DeviceSoftwareAssay
Industry: Pathology

Partnerships

Collaborates with academic institutions via technology adoption

Beyond the preview

Go deeper on Bruker Spatial Biology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bruker Spatial Biology.

Explore the full profile